What is the current Prelude Therapeutics share price?
The current share price of Prelude Therapeutics is US$ 0,81
How many Prelude Therapeutics shares are in issue?
Prelude Therapeutics has 56.460.481 shares in issue
What is the market cap of Prelude Therapeutics?
The market capitalisation of Prelude Therapeutics is USD 45,55M
What is the 1 year trading range for Prelude Therapeutics share price?
Prelude Therapeutics has traded in the range of US$ 0,6101 to US$ 6,80 during the past year
What is the PE ratio of Prelude Therapeutics?
The price to earnings ratio of Prelude Therapeutics is -0,36
What is the cash to sales ratio of Prelude Therapeutics?
The cash to sales ratio of Prelude Therapeutics is 6,53
What is the reporting currency for Prelude Therapeutics?
Prelude Therapeutics reports financial results in USD
What is the latest annual turnover for Prelude Therapeutics?
The latest annual turnover of Prelude Therapeutics is USD 7M
What is the latest annual profit for Prelude Therapeutics?
The latest annual profit of Prelude Therapeutics is USD -127,17M
What is the registered address of Prelude Therapeutics?
The registered address for Prelude Therapeutics is 200 POWDER MILL ROAD, WILMINGTON, DELAWARE, 19803
What is the Prelude Therapeutics website address?
The website address for Prelude Therapeutics is www.preludetx.com
Which industry sector does Prelude Therapeutics operate in?
Prelude Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector